![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessTrabecular bone volume and osteoprotegerin expression in uremic rats given high calcium
Calcium (Ca)-containing phosphate binders have been recommended for the treatment of hyperphosphatemia in children with chronic kidney disease. To study the effects of high Ca levels on trabecular bone volume ...
-
Article
Sevelamer hydrochloride: an effective phosphate binder in dialyzed children
This pilot study was designed to evaluate the efficacy and acceptability of sevelamer hydrochloride as a phosphate binder in pediatric patients treated with dialysis. A 6-month open-label trial of sevelamer hy...
-
Article
Bone density measurements in pediatric patients with renal osteodystrophy
Peripheral quantitative computed tomography (pQCT) can selectively measure the densities of cortical and trabecular bone, but there is limited information about its use in patients with renal osteodystrophy. T...
-
Article
Cell biology of renal osteodystrophy
Renal osteodystrophy, a well-recognized complication of chronic renal failure, encompasses a spectrum of skeletal disorders ranging from high-turnover lesions of secondary hyperparathyroidism, the most common...
-
Article
Growth hormone and the skeleton in pediatric renal allograft recipients
Recombinant human growth hormone has been utilized to augment linear growth in pediatric renal allograft recipients. The skeletal changes that accompany growth hormone therapy have not been described in childr...
-
Article
An Animal Model To Evaluate Key Regulators of Endochondral Bone Growth in Renal Failure
-
Article
Skeletal Effects of Growth Hormone and Calcitriol in Children with ESRD